4.6 Editorial Material

Why dystrophin quantification is key in the eteplirsen saga

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Biochemistry & Molecular Biology

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga

Annemieke Aartsma-Rus et al.

NUCLEIC ACID THERAPEUTICS (2017)

Article Clinical Neurology

Dystrophin quantification Biological and translational research implications

Karen Anthony et al.

NEUROLOGY (2014)

Article Clinical Neurology

Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials

Virginia Arechavala-Gomeza et al.

NEUROMUSCULAR DISORDERS (2010)